A study by Israel’s largest healthcare provider on Sunday found that after participants received two doses of Pfizer’s coronavirus vaccine, they saw a 94% drop in symptomatic COVID-19 infections, according to a report.
A study by Israel’s largest healthcare provider on Sunday found that after participants received two doses of Pfizer’s coronavirus vaccine, they saw a 94% drop in symptomatic COVID-19 infections, according to a report.
